IVF And The Legacy Of Its Inventors
By John Farrell,
Forbes
| 04. 12. 2013
[Quotes CGS's Marcy Darnovsky]
Robert G. Edwards, who won a Nobel Prize in 2010 for co-developing in-vitro fertilization, has died this week. He was 87. The first so-called test-tube baby, Louise Brown, whom he helped bring into the world, was born in 1978.
But 35 years later, the assisted reproduction industry that his work helped launch in the US remains controversial.
And it’s not hard to see why, according to this paper from the Center for Genetics and Society in Berkeley, CA.
The assisted reproduction field has so far developed largely outside the realm of public policy and with little public discussion about how new technologies should be used and who should have access to them. Difficult questions have had minimal public airing. Should access to reproductive technologies be limited to those who can pay for them? Should the characteristics of future children be pre-determined? What about efforts to develop extreme technologies such as reproductive cloning or genetic techniques for producing “enhanced” children? How can we safeguard the well-being of everyone involved in assisted reproduction, including children who are produced and third parties...
Related Articles
Since the “CRISPR babies” scandal in 2018, no additional genetically modified babies are known to have been born. Now several techno-enthusiastic billionaires are setting up privately funded companies to genetically edit human embryos, with the explicit intention of creating genetically modified children.
Heritable genome editing remains prohibited by policies in the overwhelming majority of countries that have any relevant policy, and by a binding European treaty. Support for keeping it legally off limits is widespread, including among scientists...
By Ed Cara, Gizmodo | 06.22.2025
In late May, several scientific organizations, including the International Society for Cell and Gene Therapy (ISCT), banded together to call for a 10-year moratorium on using CRISPR and related technologies to pursue human heritable germline editing. The declaration also outlined...
By Elise Kinsella, ABC News | 06.15.2025
When *Sarah and her partner needed fertility testing, it was Monash IVF that the pair turned to.
"Having a quick browse online, Monash IVF was one of the most prominent ones that came up on Google search and after contacting...
By Tory Shepherd, The Guardian | 06.13.2025
IVF is “big business” and experts are concerned about conflicts of interest between profit-making and helping families have children.
Monash IVF’s second embryo bungle has sparked renewed scrutiny on the IVF industry as a whole amid calls for national regulation...